Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2023 - 01 - 31 crawled time : 13:20 save search
Context Therapeutics’ Clinical Partner Stemline Therapeutics, a Subsidiary of Menarini Group Receives FDA Approval of ORSERDU™ (elacestrant) in ER+, HER2-, ESR1-mutated Breast Cancer
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
CNTX | $1.385 -0.36% -0.36% 46K
|
Health Technology
|
| O: 78.62%
H: 27.05%
C: -13.11%
fda breast approval cancer group elascestrant orserdu ona-xr her2- her2
Halberd to Conduct Animal Tests of Nasal Spray that Blocks Negative Effects of Head Trauma
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
HALB | $0.0089 7.14% 1.1M
|
n/a
|
| O: 15.38%
H: 0.0%
C: -5.56%
spray animal negative
Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orphan Drug Exclusivity from U.S. FDA
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
|
| O: 0.68%
H: 0.0%
C: 0.0%
FENC M | $10.5 -3.05% -3.14% 100K
|
Health Technology
|
| O: -0.21%
H: 8.3%
C: 6.49%
pedmark fda pharmaceuticals drug
BPA Solutions Confirms Initial Order of Units to a University in North Carolina To Improve Indoor Air Quality
Published: 2023-01-31 (Crawled : 13:20) - singlepoint.com
SING | $0.1937 -3.63% 2.74% 150K
|
|
| O: -1.67%
H: 9.83%
C: 6.95%
air solutions order
Karuna Therapeutics Appoints William P. Kane as Chief Commercial Officer
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
KRTX | $329.83 0.0% 1.9M
|
Health Technology
|
| O: 0.74%
H: 3.19%
C: 1.5%
commercial therapeutics
Emergent Health Appoints Former Kraft Foods Director of National Accounts Charlie McMenamin to Its Board of Directors
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
EMGE | $0.0028 94.44% 4.7M
|
Wholesale Trade
|
| O: 2.13%
H: 8.33%
C: -2.08%
foods health
Casma Therapeutics Announces CEO Transition
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
CRIS | $14.96 -6.21% -6.62% 20K
|
Health Technology
|
| O: 0.64%
H: 2.2%
C: -5.04%
ceo therapeutics
Athira Pharma Announces Promotion of Kevin Church, Ph.D., to Chief Scientific Officer
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
ATHA | $2.07 -1.9% -1.93% 200K
|
Health Technology
|
| O: 0.26%
H: 5.13%
C: 3.59%
pharma
Optinose Announces CEO Transition and Business Update
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.19%
H: 1.07%
C: 1.06%
OPTN | $0.9293 -8.89% -9.76% 550K
|
Health Services
|
| O: 0.57%
H: 6.29%
C: 2.29%
ceo update
KemPharm Enhances Senior Management Team
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.19%
H: 1.07%
C: 1.06%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
management
Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023
Published: 2023-01-31 (Crawled : 13:20) - prnewswire.com
AEMD A | $1.43 0.7% 0.7% 2.3K
|
Health Technology
|
| O: -9.18%
H: 8.81%
C: 1.79%
conference medical
Rakuten Advertising named mThink's Best Affiliate Network for 12 Consecutive Years
Published: 2023-01-31 (Crawled : 13:20) - prnewswire.com
RKUNF | $5.378 -22.65% 5.1K
|
Consumer Services
|
| O: -2.53%
H: 2.2%
C: 2.2%
RKUNY | $5.235 1.45% 42K
|
Retail Trade
|
| O: 1.18%
H: 0.0%
C: -2.13%
network
Reviva Pharmaceuticals to Present at the 2023 BIO CEO and Investor Conference
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
RVPH | $3.03 -5.31% -5.61% 120K
|
|
| O: 1.15%
H: 13.47%
C: 8.68%
pharmaceuticals ceo conference
Aptinyx to Present at the SVB Securities Global Biopharma Conference
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
APTX | $0.061 21.31% 7.8M
|
Health Services
| Email alert
Add to watchlist
biopharma global conference
CADIZ INC. ANNOUNCES $40 MILLION REGISTERED DIRECT OFFERING BACKED BY LARGEST SHAREHOLDERS
Published: 2023-01-31 (Crawled : 13:20) - prnewswire.com
CDZI A | $2.25 4.65% 4.44% 260K
|
Utilities
|
| O: 1.04%
H: 3.61%
C: 3.09%
offering direct
“Nothing defensive” about Marsh McLennan restructuring – CEO – Insurance Business
Published: 2023-01-31 (Crawled : 13:20) - spacfeed.com
BACA | $10.36 -0.29% 0.19% 44K
|
n/a
|
| O: 0.0%
H: 0.0%
C: 0.0%
EXPR | News | $2.52 0.0% 120K
|
Retail Trade
|
| O: 0.0%
H: 3.48%
C: 0.87%
ceo insurance
9 Meters Biopharma to Present at the 2023 BIO CEO & Investor Conference
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
NMTR | $0.0722 -42.97% -67.9% 10M
|
Health Technology
|
| O: 0.5%
H: 4.5%
C: 1.0%
biopharma ceo conference
Chunghwa Telecom Reports 2023 Guidance
Published: 2023-01-31 (Crawled : 13:20) - prnewswire.com
CHT | News | $38.16 0.42% 0.0% 61K
|
Communications
|
| O: -1.18%
H: 0.0%
C: -1.88%
CureVac von LexisNexis® als einer der weltweit dynamischsten Innovatoren ausgezeichnet
Published: 2023-01-31 (Crawled : 13:20) - curevac.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 2.04%
H: 0.0%
C: -3.67%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.85%
H: 0.31%
C: -0.45%
CVAC | $2.44 -5.06% -5.33% 710K
|
Health Technology
|
| O: -1.73%
H: 3.25%
C: -5.62%
lexisnexis als
Amneal to Report Fourth Quarter and Full Year 2022 Results on March 2, 2023
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
AMRX | $5.36 -1.83% -1.87% 840K
|
Health Technology
|
| O: 0.96%
H: 4.27%
C: 4.27%
report year results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.